https://bay2402234inhibitor.co....m/the-actual-revised
We conducted a randomized controlled interventional study from January 2019 to December 2020. The analysis included a total of 60 patients (60 eyes) with main pterygium. We defined two categories of 30 customers each. Group A received an intralesional shot of bevacizumab (Avastin), 1 month before surgery (lesion excision and conjunctival autograft). Group B (control) had only the medical procedures. Clients were followed up 7 days (D7), 1 month (M1), a few months (M3), and half a yea
Like
Comment
Share
